Drugs prohibition is criminals’ gain, neuroscience’s loss

Slides:



Advertisements
Similar presentations
Silver linings for patients with depression? Michael Gross Current Biology Volume 24, Issue 18, Pages R851-R854 (September 2014) DOI: /j.cub
Advertisements

Latin America’s resources: Blessing or curse? Michael Gross Current Biology Volume 24, Issue 6, Pages R209-R211 (March 2014) DOI: /j.cub
Cuban efforts bolstered
Volume 15, Issue 21, Pages R855-R856 (November 2005)
Genetic traces of mankind’s migrations
Volume 23, Issue 19, Pages R855-R857 (October 2013)
New directions in crop protection
Volume 20, Issue 5, Pages R219-R220 (March 2010)
Volume 23, Issue 19, Pages R855-R857 (October 2013)
French researchers ponder election prospects
Pushing stem cells to market
Anniversary send-offs
World gears up to water shortages
Volume 19, Issue 4, Pages R147-R148 (February 2009)
EU ban puts spotlight on complex effects of neonicotinoids
Volume 19, Issue 5, Pages R180-R181 (March 2009)
Hopes and fears for future of coral reefs
Red Head: US-style creationism spreads to Europe
Cuban efforts bolstered
Europe challenged on GM crops
Volume 26, Issue 11, Pages R445-R447 (June 2016)
Darwin’s meadow revisited
Bird flu fears heading west
Volume 23, Issue 24, Pages R1063-R1065 (December 2013)
Social Evolution: Slimy Cheats Pay a Price
Infant cognition Current Biology
Volume 20, Issue 5, Pages R223-R224 (March 2010)
Worries over conservation plans
Where next for China’s population policy?
Drugs prohibition is criminals’ gain, neuroscience’s loss
Learning to live with landscape fires
Chimpanzees, our cultured cousins
Volume 20, Issue 12, Pages R500-R501 (June 2010)
American birds: Audubon was not the first
Can we change our biased minds?
Can science relate to our emotions?
Animal Evolution: Last Word on Sponges-First?
New fears over bee declines
Deaf white cats Current Biology
Boom time for neuroscience in China
Volume 20, Issue 5, Pages R219-R220 (March 2010)
Volume 23, Issue 9, Pages R364-R365 (May 2013)
A new continent for human evolution
Europe challenged on GM crops
Where wildlife and tame life collide
New hopes for gene therapy
Fresh look at potential cannabis therapies
Learning to live with landscape fires
Volume 18, Issue 24, Pages R1115-R1116 (December 2008)
Volume 20, Issue 14, Pages R590-R591 (July 2010)
Feeding the future world
Volume 16, Issue 15, Pages R565-R566 (August 2006)
Volume 7, Issue 6, Pages R147-R151 (June 2000)
Growing threat of superbugs
Hopes pinned on biofuel
Volume 18, Issue 13, Pages R535-R536 (July 2008)
Conservation Biology: The Importance of Wilderness
Volume 19, Issue 20, Pages R922-R923 (November 2009)
Volume 19, Issue 5, Pages R180-R181 (March 2009)
American birds: Audubon was not the first
Volume 28, Issue 3, Pages R89-R92 (February 2018)
New insights into coral reef threats
Volume 20, Issue 13, Pages R555-R556 (July 2010)
Volume 19, Issue 23, Pages R1058-R1059 (December 2009)
Volume 23, Issue 24, Pages R1063-R1065 (December 2013)
Volume 15, Issue 9, Pages R318-R319 (May 2005)
Watching two billion people
Volume 18, Issue 5, Pages R198-R202 (March 2008)
World gears up to water shortages
Energy U-turn in Germany
Presentation transcript:

Drugs prohibition is criminals’ gain, neuroscience’s loss Michael Gross  Current Biology  Volume 23, Issue 14, Pages R585-R588 (July 2013) DOI: 10.1016/j.cub.2013.07.012 Copyright © 2013 Terms and Conditions

Heroic invention: The company Bayer had great hopes for its new painkiller, heroin, at the beginning of the 20th century. Within two decades, however, its dreams turned into a nightmare. (Photo: Wikimedia Commons.) Current Biology 2013 23, R585-R588DOI: (10.1016/j.cub.2013.07.012) Copyright © 2013 Terms and Conditions

Green shoots: The cannabis plant (Cannabis sativa) can look back on millennia of usefulness to mankind, from hemp fibres used in the Gutenberg bible through to medications given to Queen Victoria. Its criminalisation under global drug treaties induces people to try alternatives that aren’t banned yet, but may be more dangerous. (Photo: © GW Pharmaceuticals.) Current Biology 2013 23, R585-R588DOI: (10.1016/j.cub.2013.07.012) Copyright © 2013 Terms and Conditions

Pain relief: Sativex™ is a cannabis-based prescription drug developed by GW Pharmaceuticals in the UK and licensed for treatment of pain and spasticity in multiple sclerosis. (Photo: © GW Pharmaceuticals.) Current Biology 2013 23, R585-R588DOI: (10.1016/j.cub.2013.07.012) Copyright © 2013 Terms and Conditions

Psychedelic molecule: Albert Hofmann, the inventor and first user of LSD, with a model of the molecule he called his ‘problem child’. Far from seeing it as a recreational drug, Hofmann hoped that it would enable people to gain a deeper understanding of consciousness and spirituality. (Photo: istockphoto.com.) Current Biology 2013 23, R585-R588DOI: (10.1016/j.cub.2013.07.012) Copyright © 2013 Terms and Conditions